Litcius/Paper detail

Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines

Sepideh Atri, Nikoo Nasoohi, Mahshid Hodjat

2020Current Molecular Pharmacology15 citationsDOI

Topics & Concepts

Trichostatin ATelomeraseHistone deacetylase inhibitorTelomerase reverse transcriptaseCancer researchHead and neck squamous-cell carcinomaAzacitidineEpigeneticsDNA methylationHistone deacetylaseBiologyMolecular biologyChemistryGene expressionHistoneCancerHead and neck cancerGeneGeneticsTelomeres, Telomerase, and SenescenceHistone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation
Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines | Litcius